Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 7Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Colorectal Neoplasms 2Breast Neoplasms 2Substance-Related Disorders 1Prostatic Neoplasms 1Primary Myelofibrosis 1Opioid-Related Disorders 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Intellectual Disability 1Hodgkin Disease 1Hematologic Neoplasms 1Genital Neoplasms, Female 1Cancer Survivor 1Brain Neoplasms 1Anemia, Aplastic 1

Interventions

Ultrasonic Waves 1Therapeutics 1Educational Status 1Dosage Forms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Substance-Related Disorders × Educational Status × Lymphoid × Clear all
NCT04921787 2026-04-23

EXHITENTRE

Hennepin Healthcare Research Institute

Phase NA Active not recruiting
24 enrolled
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡